“INVESTIGATION OF MODIFIED SORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA VIA MOLECULAR DOCKING”, FMHR, vol. 4, no. 5, pp. 567–585, May 2026, Accessed: May 21, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/2904